References
- Jemal A, Siegel R, Xu J, et al. Cancer statistics, 2010. Cancer J Clin 2010;60:277–300
- Yokota J, Kohno T. Molecular footprints of human lung cancer progression. Cancer Sci 2004;95:197–204
- Pallis AG, Fennell DA, Szutowicz E, et al. Biomarkers of clinical benefit for anti-epidermal growth factor receptor agents in patients with non-small-cell lung cancer. Br J Cancer 2011;105:1–8
- Cai J, Wu J, Zhang H, et al. miR-186 downregulation correlates with poor survival in lung adenocarcinoma, where it interferes with cell-cycle regulation. Cancer Res 2013;73:756–66
- Ohmstede CA, Farrell FX, Reep BR, et al. RAP2B: a RAS-related GTP-binding protein from platelets. Proc Natl Acad Sci USA 1990;87:6527–31
- Farrell FX, Ohmstede CA, Reep BR, et al. cDNA sequence of a new ras-related gene (rap2b) isolated from human platelets with sequence homology to rap2. Nucleic Acids Res 1990;18:4281
- Zhang X, He Y, Lee KH, et al. Rap2b, a novel p53 target, regulates p53-mediated pro-survival function. Cell Cycle 2013;12:1279–91
- Zhang Q, Duan L, Xu H, et al. [Effects of Rap2b gene on foci formation and wound-healing of NIH3T3 cells]. Wei Sheng Yan Jiu 2010;39:403–6
- Xie X, Liu H, Wang M, et al. miR-342-3p targets RAP2B to suppress proliferation and invasion of non-small cell lung cancer cells. Tumour Biol 2015;36:5031–8
- Nguyen DX, Bos PD, Massague J. Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer 2009;9:274–84
- Sahai E. Illuminating the metastatic process. Nat Rev Cancer 2007;7:737–49
- Osada H, Takahashi T. Genetic alterations of multiple tumor suppressors and oncogenes in the carcinogenesis and progression of lung cancer. Oncogene 2002;21:7421–34
- Bourne HR, Sanders DA, McCormick F. The GTPase superfamily: a conserved switch for diverse cell functions. Nature 1990;348:125–32
- Bourne HR, Sanders DA, McCormick F. The GTPase superfamily: conserved structure and molecular mechanism. Nature 1991;349:117–27
- Rundhaug JE. Matrix metalloproteinases and angiogenesis. J Cell Mol Med 2005;9:267–85
- Deryugina EI, Quigley JP. Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev 2006;25:9–34
- Overall CM, Kleifeld O. Tumour microenvironment – opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy. Nat Rev Cancer 2006;6:227–39
- Badiga AV, Chetty C, Kesanakurti D, et al. MMP-2 siRNA inhibits radiation-enhanced invasiveness in glioma cells. PLoS One 2011;6:e20614
- Cha HJ, Bae SK, Lee HY, et al. Anti-invasive activity of ursolic acid correlates with the reduced expression of matrix metalloproteinase-9 (MMP-9) in HT1080 human fibrosarcoma cells. Cancer Res 1996;56:2281–4
- Brooks PC, Stromblad S, Sanders LC, et al. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3. Cell 1996;85:683–93
- Dhillon AS, Hagan S, Rath O, et al. MAP kinase signalling pathways in cancer. Oncogene 2007;26:3279–90
- Bermudez O, Pages G, Gimond C. The dual-specificity MAP kinase phosphatases: critical roles in development and cancer. Am J Physiol Cell Physiol 2010;299:C189–202
- Diab S, Kumarasiri M, Yu M, et al. MAP kinase-interacting kinases-emerging targets against cancer. Chem Biol 2014;21:441–52
- Xu ST, Zou FZ, Cai LN, et al. The downregulation of OPN inhibits proliferation and migration and regulate activation of ERK1/2 in ECA-109 cells. Int J Clin Exp Med 2015;8:5361–9
- Poudel B, Lee YM, Kim DK. DDR2 inhibition reduces migration and invasion of murine metastatic melanoma cells by suppressing MMP2/9 expression through ERK/NF-κB pathway. Acta Biochim Biophys Sin 2015;47:292–8
- Liu YW, Zuo PY, Zha XN, et al. Octacosanol enhances the proliferation and migration of human umbilical vein endothelial cells via activation of the PI3K/Akt and MAPK/ERK pathways. Lipids 2015;50:241–51
- Dimchev GA, Al-Shanti N, Stewart CE. Phospho-tyrosine phosphatase inhibitor Bpv(Hopic) enhances C2C12 myoblast migration in vitro. Requirement of PI3K/AKT and MAPK/ERK pathways. J Muscle Res Cell Motil 2013;34:125–36
- Williams KA, Zhang M, Xiang S, et al. Extracellular signal-regulated kinase (ERK) phosphorylates histone deacetylase 6 (HDAC6) at serine 1035 to stimulate cell migration. J Biol Chem 2013;288:33156–70